News-Medical.netCRISPR-like gene editing could be potential way to treat patients with harmful blood lipid levelsNews-Medical.netUsing a variation of CRISPR gene editing may be a potential strategy for mimicking the protective effects of a genetic muta… Continue reading
Technology NetworksTechnology Helps Harness the Full Potential of Gene TherapyTechnology Networks"Non-chemical, non-viral approaches, which take advantage of mechanical or electrical stimuli to overcome cellular barriers to gene transfer, are comp… Continue reading
Technology NetworksTechnology Helps Harness the Full Potential of Gene TherapyTechnology Networks"Non-chemical, non-viral approaches, which take advantage of mechanical or electrical stimuli to overcome cellular barriers to gene transfer, are comp… Continue reading
Business Wire (press release) |
Charpentier/Doudna Patent Covering CRISPR-Cas9 Gene Regulation Applications
Business Wire (press release) DUBLIN–(BUSINESS WIRE)–ERS Genomics announced today that the European Patent Office (EPO) has granted Dr. Emmanuelle Charpentier, ERS Genomics’ co-founder, together with the University of California and University of Vienna, its second EU patent with … |
Business Wire (press release) |
Charpentier/Doudna Patent Covering CRISPR-Cas9 Gene Regulation Applications
Business Wire (press release) DUBLIN–(BUSINESS WIRE)–ERS Genomics announced today that the European Patent Office (EPO) has granted Dr. Emmanuelle Charpentier, ERS Genomics’ co-founder, together with the University of California and University of Vienna, its second EU patent with … |
Financial Times |
‘Holy grail’ of gene therapy still a long way off for cystic fibrosis
Financial Times Until six years ago, there was nothing that could stop the relentless march of cystic fibrosis, a relatively rare disease that affects roughly 75,000 people worldwide, which causes the build-up of thick mucus in the lungs, pancreas, and other organs … |